Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	18298
Country	United States

Received	2015-04-15 08:53
Peer-Review Started	2015-04-16 17:51
To Make the First Decision	2015-06-25 17:53
Return for Revision	2015-07-01 10:07
Revised	2015-07-07 20:48
Second Decision	2015-07-21 19:37
Accepted by Journal Editor-in-Chief	2015-07-23 20:21
Accepted by Executive Editor-in-Chief	2015-08-11 15:16
Articles in Press	2015-08-11 15:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-10 20:09
Publish the Manuscript Online	2015-10-19 09:39

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Management of borderline resectable pancreatic cancer
Manuscript Source	Invited Manuscript
All Author List	Amit Mahipal, Jessica Frakes, Sarah Hoffe and Richard Kim
Funding Agency and Grant Number
Corresponding Author	Richard Kim, MD, Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive FOB-2, Tampa, FL 33612, United States. richard.kim@moffitt.org
Key Words	Pancreatic cancer; Surgery; Chemotherapy; Radiation; Borderline
Core Tip	The diagnosis and treatment of borderline resectable pancreatic cancer (BRPC) remains unclear. The definition of BRPC is not uniform and generally refers to regional blood vessel involvement by the tumor. Recent attempts have been made to standardize the definition of BRPC. Neoadjuvant therapy is recom-mended in the hopes of obtaining negative surgical margins and consists of chemotherapy and radiation therapy. Data for therapeutic approaches is primarily derived from single institution retrospective series. In this article, we review the definition, imaging modalities for diagnosis and treatment of patients with BRPC.
Publish Date	2015-10-19 09:39
Citation	Mahipal A, Frakes J, Hoffe S, Kim R. Management of borderline resectable pancreatic cancer. World J Gastrointest Oncol 2015; 7(10): 241-249
URL	http://www.wjgnet.com/1948-5204/full/v7/i10/241.htm
DOI	http://dx.doi.org/10.4251/wjgo.v7.i10.241

Full Article (PDF)	WJGO-7-241.pdf
Full Article (Word)	WJGO-7-241.doc
Manuscript File	18298-Review.docx
Answering Reviewers	18298-Answering reviewers.pdf
Audio Core Tip	18298-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	18298-Conflict-of-interest statement.pdf
Copyright License Agreement	18298-Copyright assignment.pdf
Peer-review Report	18298-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	18298-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	18298-Scientific misconduct check.pdf
Scientific Editor Work List	18298-Scientific editor work list.pdf